Bifogade filer
Vimian Group AB (publ) publishes prospectus in connection with its listing on Nasdaq Stockholm’s Main Market
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Vimian Group AB (publ) (”Vimian” or the ”Company”) announced on 14 March 2025 that Nasdaq Stockholm’s listing committee had approved Vimian’s application to admit the Company’s ordinary shares to trading on Nasdaq Stockholm’s Main Market. The prospectus that has been prepared in connection with the uplisting has today been approved and registered by the Swedish Financial Supervisory Authority (the “SFSA”) and is now available on Vimian’s website, www.vimian.com, and on the SFSA’s website, www.fi.se.
The first day of trading on Nasdaq Stockholm is expected to be Friday, 28 March 2025 and the last day of trading on Nasdaq First North Growth Market is expected to be Thursday, 27 March 2025. Vimian’s ordinary shares will be traded in the Large Cap segment with unchanged ticker (VIMIAN) and unchanged ISIN code (SE0015961982). There will be no offer or issuance of new shares in connection with the change of marketplace to Nasdaq Stockholm and shareholders in Vimian do not need to take any action in connection therewith.
Advokatfirman Vinge is acting as legal advisor to Vimian in connection with the listing on Nasdaq Stockholm.